Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,322 | -47,049 | -46,446 | -40,598 | -6,381 |
| Depreciation Amortization | 11,865 | 49,555 | 37,150 | 24,875 | 11,785 |
| Income taxes - deferred | 43 | -5,394 | -8,609 | -8,098 | 81 |
| Accounts receivable | 9,004 | -10,666 | -4,874 | -21,933 | -1,958 |
| Other Working Capital | -31,201 | -11,780 | -9,672 | -9,214 | -14,757 |
| Other Operating Activity | -5,720 | 64,129 | 51,924 | 64,125 | 5,225 |
| Operating Cash Flow | $-19,331 | $38,795 | $19,473 | $9,157 | $-6,005 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -826 | -1,006 | -432 | -368 | -291 |
| Net Acquisitions | N/A | 24,678 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -709 | -709 | -709 | -709 |
| Investing Cash Flow | $-826 | $22,963 | $-1,141 | $-1,077 | $-1,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | N/A | 0 | 0 | 0 |
| Debt Repayment | -5,000 | -59,584 | -11,320 | -11,320 | -3,056 |
| Common Stock Issued | 150 | 2,442 | 1,339 | 786 | 177 |
| Other Financing Activity | -9,203 | 2,562 | -1,744 | -1,553 | -1,363 |
| Financing Cash Flow | $947 | $-54,580 | $-11,725 | $-12,087 | $-4,242 |
| Exchange Rate Effect | 430 | -2,560 | -497 | -963 | -544 |
| Beginning Cash Position | 41,582 | 36,964 | 36,964 | 36,964 | 36,964 |
| End Cash Position | 22,802 | 41,582 | 43,074 | 31,994 | 25,173 |
| Net Cash Flow | $-18,780 | $4,618 | $6,110 | $-4,970 | $-11,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,331 | 38,795 | 19,473 | 9,157 | -6,005 |
| Capital Expenditure | -826 | -1,006 | -432 | -368 | -291 |
| Free Cash Flow | -20,157 | 37,789 | 19,041 | 8,789 | -6,296 |